Last Updated: 2007-12-21 12:00:38 -0400 (Reuters Health) By Megan Rauscher NEW YORK (Reuters Health) - Results of a Swedish study of mainly premenopausal women at enrollment does not provide any evidence that total dietary fat or intake of monounsaturated fat (MUFA), polyunsaturated fat (PUFA), or

Last Updated: 2007-12-26 17:00:21 -0400 (Reuters Health) NEW YORK (Reuters Health) - In women with advanced breast cancer, progression-free survival (that is, a patient remaining alive without the disease getting worse) is improved with the addition of Avastin to the commonly-used drug paclitaxel,

According to the results of a study presented at the 2007 San Antonio Breast Cancer Symposium (SABCS), the targeted agent Tykerb® (lapatinib), used in combination with the chemotherapy drug Xeloda® (capecitabine), reduces the size of brain metastases in some women with previously-treated HER2-positi

Among postmenopausal women with early, hormone receptor-positive breast cancer, updated results from the ATAC study continue to show that treatment with the aromatase inhibitor Arimidex® (anastrozole) results in a lower risk of breast cancer recurrence than treatment with tamoxifen. These results we

News Courtesy of the Marshall Memorial Fellowship WASHINGTON, D.C. – December 12, 2007– Fifty-three emerging American leaders representing 17 states and the District of Columbia have been awarded the prestigious Marshall Memorial Fellowship (MMF) for 2008. They will each spend 23 days in Europe v

According to an article recently published in the Annals of Oncology, longer follow-up results indicate that the chemotherapy agent Taxotere® (docetaxel) remains superior to the chemotherapy agent Taxol® (paclitaxel) in the treatment of metastatic breast cancer among patients who have received prior

The Oncology Drugs Advisory Drugs Committee (ODAC) of the United States Food and Drug Advisory (FDA) has recommended against FDA approval of Avastin® (bevacizumab) as initial therapy for metastatic breast cancer. Metastatic breast cancer refers to cancer that has spread to distant sites in the bo

A large study conducted in Sweden and published in the British Journal of Cancer found no overall association between total dietary fat or specific types of dietary fat and risk of breast cancer. Researchers have long speculated that there could be a link between high-fat diets and risk of breast

Among women with breast cancer that has spread to the bone, non-White women are more likely than White women to report severe pain. These results were published in the journal Cancer. The spread of cancer from its site of origin to another location in the body is called metastasis. Bone is one of

According to an early online publication in the Journal of Clinical Oncology, the American Society of Clinical Oncology (ASCO) has included Oncotype DX™ into its clinical guidelines for early breast cancer. Although chemotherapy is recommended for many women with early-stage, node-negative breast